Join World Antibody Focus 2011

WHAT Makes World Antibody Focus 2011 Unique?
Focus on Antibody Innovation and Advances
Approach the Latest Development and Trends of Global Antibody Industry
Showcase the Forefront of both Business strategy and technology
Optimize Antibody Production, Engineering & Design
Discover New Antibody Projects and Investment Opportunities in Asia and China

WHAT's Unique?
  • 300+ Antibody Industry Elites
  • 200+ Biotech Company Senior Executives
  • 30+ Industry Premier Speakers
  • 20+ Hours of Networking with Industry Leaders
  • 10+ In-depth Case Studies from worldwide
     -->>Register to attend World Antibody Focus 2011

Past and Present Distinguished Speakers Including:
Zhenping Zhu
Executive Vice President, Biologics President and CEO, Kadmon China
Kadmon Pharmaceuticals
Prof.Patrick Baeuerle
Senior Vice President, Chief Scientific Officer
Klaus Wilgenbus, M.D.
Corporate Senior Vice President, Global BD& Licensing/Strategy
Boehringer Ingelheim
Wei Zhang
Director General, Department of Drug Registration
State Food and Drug Administration
Dr.Jin-San Yoo,Ph.D.
President and CEO
Mingde XIA, Ph.D.
Senior Director, COSAT
Johnson & Johnson
Prof. Yajun Guo
Chinese Engineering Research Center for Antibody Medicine
Kathleen Metters
Senior Vice President and Head of External Discovery and Preclinical Sciences
Merck Research Laboratories
Oliver Zhang
Vice President, Antibody Drug Development
Roger Perlmutter Ph.D
Executive Vice President R&D
Prof.Zhinan Chen
Director, Cell Engineering Research Center, Department of Cell Biology
The Fourth Military Medical University
Andrew Buchanan
Senior Team Leader and Scientist
Jian Gao
Director of R&D Center
North China Pharmaceutical Group Corporation
James Zhao
Vivo Ventures

Agenda at a glance:
  DAY 1, Thursday, November 17
AM Aligning Corporate Strategy with Changing Business Landscape(Regulatory Affairs, Partnering & Licensing Opportunities, Biosimilar Antibodies and Beyond) Concurrent One-to-One Meetings
& Exhibition
PM Target Discovery, Pre-Clinical and Clinical Development of Antibody
  DAY 2, Friday, November 18
AM Current and Novel Antibody-based Therapies Concurrent One-to-One Meetings
& Exhibition
PM Antibody Engineering & Design, Protein Development, Production & Purification
  -->>Register to attend World Antibody Focus 2011

VIP Login


Copyright 2004-2011 China Decision Makers Consultancy (CDMC),All rights reserbved
T: +86 21 68407631 F: +86 21 68407633 E: jasonzh@cdmc.org.cn | 沪ICP备08011529号